AzTrials
AzTrials

AgingNCT06842784

Impact of Extreme Heat on Myocardial Blood Flow and Flow Reserve in Young and Older Adults

An observational study of Aging and Heat Stress, run by University of Texas Southwestern Medical Center at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Extreme heat causes a disproportionate number of hospitalizations and deaths in older adults relative to any other age group. Importantly, many hospitalizations and deaths are primarily due to cardiovascular events such as myocardial infarction. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Aging, Heat Stress, Hyperthermia
What is being tested?
Ambient heat stress
How many people
24 participants
Where
1 siteUnited States
Study dates
3 Feb 2025to 1 Feb 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population will be healthy younger and older individuals identified from the general population.

Who may be able to join

  • Healthy male and female individuals
  • 18-35 years or 65+ years of age
  • Free of any underlying moderate to serious medical conditions

Who cannot join

  • Known heart disease; other chronic medical conditions requiring regular medical therapy including cancer, diabetes, neurological diseases, uncontrolled hypertension, and uncontrolled hypercholesterolemia.
  • Taking of any medications (such as beta blockers and non-dihydropyridine calcium channel blockers) that have known influences on either cardiac function or sweating responses.
  • Abnormalities detected on routine screening.
  • Current smokers, as well as individuals who regularly smoked within the past 3 years.
  • Body mass index of greater than 30 kg/m^2
  • Pregnant individuals

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas Health Presbyterian Hospital Dallas

    Dallas, Texas, 75231

Other trials in United States

About this study

Extreme heat causes a disproportionate number of hospitalizations and deaths in older adults relative to any other age group. Importantly, many hospitalizations and deaths are primarily due to cardiovascular events such as myocardial infarction. Previous data indicate that older adults have attenuated skin blood flow and sweating responses when exposed to heat, resulting greater increase in core body temperature. Despite these observations, relatively little is known about the risk for myocardial ischemia potentially contributing to the aforementioned higher morbidity and mortality in older adults during heat waves. The broad objective of this work is to determine the impact of ambient heat exposure on myocardial blood flow and flow reserve in young and older adults. Aim 1 will test the hypothesis that older adults exhibit attenuated myocardial flow reserve compared to young adults during heat stress. Aim 2 will determine if the percent of maximal myocardial flow reserve (assess via vasodilator stress) during heat exposure is higher in older adults compared to young adults. The expected outcome from this body of work will improve our understanding of the consequences of aging on cardiovascular responses to ambient heat stress.

Being tested
Ambient heat stress
Medical subject headings
Heat Stress Disorders, Hyperthermia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ambient heat stressOther

    3-hour ambient heating in 44°C and 20% relative humidity

Study groups in NCT06842784
Study groupRoleWhat they receive
Young participantsIndividuals aged 18-39 years
Receives: Other: Ambient heat stress
Older participantsIndividuals aged 65 years or older
Receives: Other: Ambient heat stress

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Myocardial flow reserve

    Measured via myocardial contrast echocardiography.

    Measured: The difference in the change from baseline to a vasodilator stress test and the change from baseline to after 3-hours of heat stress.

  2. Myocardial blood flow

    Measured via myocardial contrast echocardiography.

    Measured: The change from baseline to after 3 hours of heat stress.

Secondary outcomes (4)
  1. Core temperature

    Measured via ingestible telemetric pill.

    Measured: The change from baseline to after 3 hours of heat stress..

  2. Indices of left and right ventricular function

    Measured via echocardiography.

    Measured: At baseline and after 3 hours of heat stress.

  3. Heart rate

    Measured via electrocardiogram.

    Measured: At baseline, during exercise- after 20 minutes and 2 hours in the heat, and at rest after 3 hours of heat stress.

  4. Blood pressure

    Measured via automated auscultation of the brachial artery.

    Measured: At baseline, during exercise- after 20 minutes and 2 hours in the heat, and at rest after 3 hours of heat stress.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2025
  2. Study start3 Feb 2025
  3. Primary completion30 Apr 2026
  4. Study completion1 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06842784
Sponsor's protocol ID
STU_2019_1759_MCE
Other IDs
1R01AG069005
Status last verified
Aug 2025
First submitted
18 Feb 2025
Last updated
30 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Aging and Heat Stress, run by University of Texas Southwestern Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 30 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Myocardial flow reserve (time frame: The difference in the change from baseline to a vasodilator stress test and the change from baseline to after 3-hours of heat stress.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in